Fiducian Group Ltd · ASX:FID
Fiducian — H1 FY2022 Earnings Presentation
25 slides from Fiducian's earnings presentation, Feb 14, 2022
Slide 1: FY 2021-22 H1 Results Investor Presentation
FY 2021-22 H1 RESULTS INVESTOR PRESENTATION Indy Singh – Executive Chairman, Fiducian Group Rahul Guha – Executive Chairman, Fiducian Services Sydney, 14 February 1
Slide 2: Agenda
Agenda • Business Overview • Financials • Growth Opportunities • Key Dates and Contacts 2
Slide 3: Platform Administration Business
Platform Administration Business 3
Slide 4: Fiducian Overview – Platform Administration
Fiducian Overview – Platform Administration • Market competitive platform offering for Investments, Superannuation and SMA administration with own licences • Investment menu includes 15 Fiducian multi-manager funds, 57 external managed funds, SMAs and Term Deposits tailored to financial adviser and
Slide 5: Fiducian Overview – Platform Administration: Revenue and PBT
Fiducian Overview – Platform Administration • Net In-flows of $163 million during first half of FY Net Funds Inflows - Six monthly (in $ mil) 180 2021-22. Both Salaried and Franchised networks 160 contributing to the Inflows 140 120 • Combination of organic flows from active referrals 100 and inorga
Slide 6: Funds Management Business
Funds Management Business 6
Slide 7: Fiducian Overview – Funds Management
Fiducian Overview – Funds Management • Fiducian provides highly effective Manage the Manager System (Multi-Manager) with greater diversification and below average risks to generate consistent above average returns • The investment team selects expert managers with proven performance, differing inves
Slide 8: Fiducian Overview – Funds Management: Fund Performance Rankings
Fiducian Overview – Funds Management • Consistently superior results against the world’s best fund managers in the Australian market 1-year return (ranking) 3-years return (ranking) 5-years return (ranking) 7-years return (ranking) 10-years return (ranking) Fiducian Funds p.a. p.a. p.a. p.a. p.a. Ca
Slide 9: Fiducian Overview – Funds Management: Revenue and Profit
Fiducian Overview – Funds Management • PDS Fund Fees are in line with Funds Revenue & PBT and Average FUM industry peer groups. Added 4.5 benefits for clients are access to 14.2 14.0 multiple managers whose fees 4.2 4.0 12.1 are paid by Fiducian through the 12.0 3.6 3.5 10.7 relevant Fiducian Fund 9
Slide 10: Fintech Capabilities
Fintech Capabilities 10
Slide 11: Fiducian Overview – FinTech Capabilities
Fiducian Overview – FinTech Capabilities • Proven and time tested Fintech capabilities underpin Fiducian’s successful business model • Recent programming team expansion and new system development provides opportunities for commercialisation • Market leading Platform Administration System, ‘Fastrack’
Slide 12: Financial Planning Business
Financial Planning Business 12
Slide 13: Fiducian Overview – Financial Planning
Fiducian Overview – Financial Planning • Enabler of steady flows to Fiducian Funds and Platform • 66 planners across 46 offices across Australia • Selective recruitment of Salaried and Franchised planners aligned to Fiducian culture driven by Quality and Expertise • Planners focused on delivering ou
Slide 14: Fiducian Overview – Acquisitions
Fiducian Overview – Acquisitions Acquisition of Financial Planning Business of People’s Choice Credit Union • 40 staff including 16 planners joined Fiducian Group on 1 February 2022 • The acquisition has added $1.1 billion in Funds under Advice from approximately 5,000 clients currently contributing
Slide 15: Financials
Financials 15
Slide 16: FY 2022 H1 Financial Highlights
FY 2022 H1 Financial Highlights FINANCIALS 16
Slide 17: Segment Reporting
Segment Reporting FINANCIALS 17
Slide 18: FID outperformance against All Ords Accum Index
FID outperformance against All Ords Accum Index FID vs All Ords Growth FID + 1126% • Since Jun 12, FID has (incl Dividends) outperformed All Ords by 954% (including dividend) 1170% FID closing on 10 Feb 2022: $8.00 • Dividend pay-out policy is 60-70% of Net Profit After 970% Tax • H1 2022 dividend i
Slide 19: Dividends – $1,000 invested on 1 July 2012
Dividends – $1,000 invested on 1 July 2012 • The graph shows that $1,000 invested in FID on 1 July 2012 delivered a fully franked dividend of $152.58 in H1 • Double digit EPS growth (based on UNPAT) in 17 out of 22 years since listing FINANCIALS 19
Slide 20: Projecting the Potential: Conceptual Representation
Projecting the Potential: Conceptual Representation The following is a conceptual extrapolation* of how increasing scale lifts EBITDA at an accelerating rate above a relatively fixed cost base: Funds under Management, Administration and Advice (FUMAA) & EBITDA • This is not a projection or a forward
Slide 21: Growth Opportunities
Growth Opportunities 21
Slide 22: Market Opportunities for Growth of the Business
Market Opportunities for Growth of the Business Potential growth via Fiducian Platform and 3rd party planners Funds Business Business $3.2 $4.4 billion billion • Capture market share from disintegration of • Distribution of MTM process to Universities, large wealth businesses Charities and Family Of
Slide 23: Key Dates and Contacts
Key Dates and Contacts Retail Investor Presentation (Online) • Time / Date: 12:30 to 1.30 pm AEST, Thursday 17 February 2022 • Join-in details: https://8x8.vc/fiduciangroup/investors.170222 (8x8 app or Google Chrome) or • Dial-in: +61 2 8015 5105 Meeting ID: 552 787 399# Key Dates • H1 Dividend Reco
Slide 24: Disclaimer
Disclaimer Information in this document and given in the presentation is of a general nature. It is not intended to be, nor does it, constitute financial, legal or tax advice. The information is given in good faith and, although care has been exercised in compiling it, Fiducian Group Limited and the
Slide 25: Disclaimer
Disclaimer Source: Morningstar Direct. © 2021 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any gene